17 mill. short squeeze imminent ., page-13

Hi Vinny,

In DB's update (dated 11 Feb 13), they comment .."Approval of the CHF phase III trial by the FDA remains a key near-term catalyst which may be just around the corner given management’s expectation to commence the trial by the end of FY13".

It would be a tremendous start to April and the best kept secret in the world will also be on feature and further emphasized at the upcoming Adult Stell conference:

The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference. Highlights Include Keynote by Nobel Prize Winner, Dr. John Gurdon

http://finance.yahoo.com/news/vaticans-pontifical-council-culture-neostem-125726421.html

MAXIM Group will be in attendance and there will be a detailed analysis on the leaders in the RM space.

In particular I welcome the discussion regarding hope for the future of adult stem cell therapy for multiple sclerosis ("MS"). IMHO, this discussion can only further reinforce the alliance b/w the Blaster and TEVA.

Good luck to all Holders and good weekend.